Government funding for uterine cancer research lags behind rising incidence
Rachel P Mojdehbakhsh, Ryan J Spencer, Natalia Gontarczyk Uczkowski, Amy L Godecker · 2026
Read Government funding for uterine cancer research lags behind rising incidence by Rachel P Mojdehbakhsh, Ryan J Spencer, Natalia Gontarczyk Uczkowski, Amy L Godecker (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13241923.txt.
Description
Mojdehbakhsh, Spencer, Uczkowski, and Godecker compare uterine cancer research funding with disease rise, in work from twenty twenty-six. Uterine cancer incidence is rising steadily in the United States. Government funding is the second largest source of cancer research money through a defense department program for peer reviewed studies.
The team compiled grants from that peer reviewed cancer program by organ site. Funding was then stratified by incidence of each disease to allow fair comparison. Uterine cancer funding lagged behind its rising incidence compared with other sites, the title states. Funding per case is a fairness lens that can guide future program priorities and advocacy.
Catalog record
| CREATOR | Rachel P Mojdehbakhsh, Ryan J Spencer, Natalia Gontarczyk Uczkowski, Amy L Godecker |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 10 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |